Allscripts Names Paul M. Black Chief Executive Officer

            Allscripts Names Paul M. Black Chief Executive Officer

Glen Tullman Steps Down as CEO and Board Member

Board of Directors Concludes Evaluation of Strategic Alternatives

PR Newswire

CHICAGO, Dec. 19, 2012

CHICAGO, Dec. 19, 2012 /PRNewswire/ --Allscripts Healthcare Solutions, Inc.
(NASDAQ: MDRX) today announced that it has named Paul M. Black as its
President and Chief Executive Officer, effective immediately. Mr. Black is
the former Chief Operating Officer of Cerner Corporation and is currently an
Allscripts board member. He replaces Glen Tullman, who will step down from
his positions as Chief Executive Officer and board member. Lee Shapiro also
will step down as President, effective immediately, and will serve as a
consultant to Mr. Black for up to six months. In addition, the Company
announced that the Board has formally concluded its evaluation of strategic

"We want to thank Glen Tullman for building Allscripts into one of the leaders
in the evolving healthcare IT industry," said Dennis Chookaszian, Allscripts
Chairman of the Board. "Glen began at the Company in 1997 when it was
unprofitable, turned Allscripts around and achieved record revenues and
profits in 2011. Along the way, Glen also grew the workforce to more than
7,000 employees. I also want to thank Lee Shapiro for his many important
contributions to Allscripts, particularly with respect to our M&A strategy and
international expansion."

Commenting on the selection of Paul M. Black as President and CEO, Mr.
Chookaszian said: "Paul possesses a unique blend of operational, healthcare
and IT sector expertise, and we are pleased that he has agreed to lead the
Company at this critical juncture.Paul's deep domain expertise in healthcare
technology, industry relationships, and understanding of Allscripts' solutions
and client base make him the ideal choice. Together with our recently
appointed Chief Financial Officer Rick Poulton, we are confident that we have
a leadership team in place that can execute on our strategic initiatives,
capitalize on the many global opportunities that lie ahead, and lead
Allscripts through its next phase of growth."

Commenting on the strategic alternatives process, Mr. Chookaszian stated: "The
Board conducted a thorough and rigorous review of strategic alternatives. The
Board concluded, however, that the best course at this time is to develop
Allscripts' long-term potential under the direction of our new management

Incoming Chief Executive Officer, Mr. Black said, "I look forward to building
on the many successes achieved by the Allscripts team. Without
underestimating the challenges ahead, we have compelling open-platform
solutions, an impressive global client base, and a very dedicated and talented
team. We will improve the execution of our strategic vision, deliver on our
worldwide client commitments, and continue to innovate.Our focus will be on
creating long-term value for our shareholders."

Glen Tullman added, "It's always been Allscripts' goal to revolutionize
healthcare and I am proud that Allscripts' employees have moved this industry
forward in both the US and abroad – enabling more people to access our
healthcare systems, adding thousands of jobs, and developing an industry that
will be one of the biggest

future growth engines of the U.S. economy.Allscripts'team has shown great
resilience and dedication, and I appreciate their hard work to build
Allscripts into a leading provider of clinical software, connectivity and
information solutions.I am confident that Allscripts is in good hands and has
a bright future ahead."

In addition to currently serving as an Allscripts board member, Mr. Black has
served on the Board of The Truman Medical Centers for 12 years, most recently
as Chairman, and as a director of Haemonetics Corporation (NYSE: HAE), a
global healthcare company dedicated to providing innovative blood-management

Mr. Black spent more than 12 years with Cerner Corporation and retired as its
Chief Operating Officer in 2007. He helped build Cerner into a market leader
in healthcare information technology solutions with more than $1.5 billion of
annual revenues. For most of his career at Cerner, Mr. Black was Chief Sales
Officer, playing an instrumental role in the company's double-digit organic
growth. Prior to Cerner, Mr. Black was with IBM from 1982 to 1994, in a
number of senior sales, marketing and professional services leadership
positions. Since 2007, he has been a Senior Advisor with New Mountain Capital
in New York and served as a Director with several New Mountain portfolio
companies. Mr. Black recently has served as an operating executive with
Genstar Capital, responsible for expanding Genstar's healthcare and software
practices, with specific focus on healthcare technology.

He received a B.S. from Iowa State University and an MBA from the University
of Iowa.

Conference Call

Allscripts will conduct a conference call tomorrow, Thursday, December 20,
2012, at 8:30 AM Eastern Time to discuss today's announcement. Investors can
access the conference via the Internet at
Participants also may access the conference call by dialing (877) 303-0543
(toll free in the US) or (973) 935-8787 (international) and requesting
Conference ID #83012880.

A replay of the call will be available two hours after the conclusion of the
call, for a period of four weeks, at or by calling
(855) 859-2056 or (404) 537-3406 - Conference ID #83012880.

About Allscripts

Allscripts(NASDAQ:MDRX) delivers the insights that healthcare providers
require to generate world-class outcomes. The company's Electronic Health
Record, practice management and other clinical, revenue cycle, connectivity
and information solutions create aConnected Community of Health™ for
physicians, hospitals and post-acute organizations. To learn more about
Allscripts, please, Twitter, YouTube and It Takes A
Community: The Allscripts Blog.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of
the federal securities laws. Statements regarding future events or
developments, our future performance, as well as management's expectations,
beliefs, intentions, plans, estimates or projections relating to the future
are forward-looking statements with the meaning of these laws. These
forward-looking statements are subject to a number of risks and uncertainties,
some of which are outlined below. As a result, no assurances can be given that
any of the events anticipated by the forward-looking statements will transpire
or occur, or if any of them do so, what impact they will have on our results
of operations or financial condition. Such risks, uncertainties and other
factors include, among other things: the possibility that the expected
synergies, efficiencies and cost savings of the merger with Eclipsys
Corporation ("Eclipsys") will not be realized, or will not be realized within
the expected time period; potential difficulties or delays in achieving
platform and product integration and the connection and movement of data among
hospitals, physicians, patients and others; the risk that the Allscripts and
Eclipsys businesses will not be integrated successfully; competition within
the industries in which we operate; failure to achieve certification under the
Health Information Technology for Economic and Clinical Health Act could
result in increased development costs, a breach of some customer obligations
and could put us at a competitive disadvantage in the marketplace; the volume
and timing of systems sales and installations, the length of sales cycles and
the installation process and the possibility that our products will not
achieve or sustain market acceptance; the timing, cost and success or failure
of new product and service introductions, development and product upgrade
releases; competitive pressures including product offerings, pricing and
promotional activities; our ability to establish and maintain strategic
relationships; undetected errors or similar problems in our software products;
the outcome of any legal proceeding that has been or may be instituted against
us; compliance with existing laws, regulations and industry initiatives and
future changes in laws or regulations in the healthcare industry, including
possible regulation of our software by the U.S. Food and Drug Administration;
the possibility of product-related liabilities; our ability to attract and
retain qualified personnel; the implementation and speed of acceptance of the
electronic record provisions of the American Recovery and Reinvestment Act of
2009; maintaining our intellectual property rights and litigation involving
intellectual property rights; risks related to third-party suppliers and our
ability to obtain, use or successfully integrate third-party licensed
technology; and breach of our security by third parties. See our Annual Report
on Form 10-K for 2011 and other public filings with the SEC for a further
discussion of these and other risks and uncertainties applicable to our
business. The statements herein speak only as of their date and we undertake
no duty to update any forward-looking statement whether as a result of new
information, future events or changes in expectations.


SOURCE Allscripts Healthcare Solutions, Inc.

Contact: Investors, Seth Frank, +1-312-506-1213,,
Media, Ariana Nikitas, +1-773-490-5657,
Press spacebar to pause and continue. Press esc to stop.